These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 25517312)

  • 1. A general approach to antibody thermostabilization.
    McConnell AD; Zhang X; Macomber JL; Chau B; Sheffer JC; Rahmanian S; Hare E; Spasojevic V; Horlick RA; King DJ; Bowers PM
    MAbs; 2014; 6(5):1274-82. PubMed ID: 25517312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated approach to extreme thermostabilization and affinity maturation of an antibody.
    McConnell AD; Spasojevich V; Macomber JL; Krapf IP; Chen A; Sheffer JC; Berkebile A; Horlick RA; Neben S; King DJ; Bowers PM
    Protein Eng Des Sel; 2013 Feb; 26(2):151-64. PubMed ID: 23173178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Use of Somatic Hypermutation for the Affinity Maturation of Therapeutic Antibodies.
    Bowers PM; Boyle WJ; Damoiseaux R
    Methods Mol Biol; 2018; 1827():479-489. PubMed ID: 30196512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody humanization by structure-based computational protein design.
    Choi Y; Hua C; Sentman CL; Ackerman ME; Bailey-Kellogg C
    MAbs; 2015; 7(6):1045-57. PubMed ID: 26252731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics.
    Datta-Mannan A; Thangaraju A; Leung D; Tang Y; Witcher DR; Lu J; Wroblewski VJ
    MAbs; 2015; 7(3):483-93. PubMed ID: 25695748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody humanization by redesign of complementarity-determining region residues proximate to the acceptor framework.
    Hanf KJ; Arndt JW; Chen LL; Jarpe M; Boriack-Sjodin PA; Li Y; van Vlijmen HW; Pepinsky RB; Simon KJ; Lugovskoy A
    Methods; 2014 Jan; 65(1):68-76. PubMed ID: 23816785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanization of antibodies using heavy chain complementarity-determining region 3 grafting coupled with in vitro somatic hypermutation.
    Bowers PM; Neben TY; Tomlinson GL; Dalton JL; Altobell L; Zhang X; Macomber JL; Wu BF; Toobian RM; McConnell AD; Verdino P; Chau B; Horlick RA; King DJ
    J Biol Chem; 2013 Mar; 288(11):7688-7696. PubMed ID: 23355464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro affinity maturation of human GM-CSF antibodies by targeted CDR-diversification.
    Steidl S; Ratsch O; Brocks B; Dürr M; Thomassen-Wolf E
    Mol Immunol; 2008 Nov; 46(1):135-44. PubMed ID: 18722015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
    MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimizing the immunogenicity of antibodies for clinical application.
    Gonzales NR; De Pascalis R; Schlom J; Kashmiri SV
    Tumour Biol; 2005; 26(1):31-43. PubMed ID: 15741769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of non-specific binding, target-mediated clearance and FcRn interactions on the pharmacokinetics of humanized antibodies.
    Datta-Mannan A; Lu J; Witcher DR; Leung D; Tang Y; Wroblewski VJ
    MAbs; 2015; 7(6):1084-93. PubMed ID: 26337808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian cell display and somatic hypermutation in vitro for human antibody discovery.
    King DJ; Bowers PM; Kehry MR; Horlick RA
    Curr Drug Discov Technol; 2014 Mar; 11(1):56-64. PubMed ID: 23978037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody humanization methods - a review and update.
    Safdari Y; Farajnia S; Asgharzadeh M; Khalili M
    Biotechnol Genet Eng Rev; 2013; 29():175-86. PubMed ID: 24568279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells.
    Choi DK; Bae J; Shin SM; Shin JY; Kim S; Kim YS
    MAbs; 2014; 6(6):1402-14. PubMed ID: 25484049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
    Hoet RM; Cohen EH; Kent RB; Rookey K; Schoonbroodt S; Hogan S; Rem L; Frans N; Daukandt M; Pieters H; van Hegelsom R; Neer NC; Nastri HG; Rondon IJ; Leeds JA; Hufton SE; Huang L; Kashin I; Devlin M; Kuang G; Steukers M; Viswanathan M; Nixon AE; Sexton DJ; Hoogenboom HR; Ladner RC
    Nat Biotechnol; 2005 Mar; 23(3):344-8. PubMed ID: 15723048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
    Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
    MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.